NEU 3.50% $14.05 neuren pharmaceuticals limited

ann: progress in orphan drug programs, page-6

  1. 194 Posts.
    interesting they released after the market closed .. it shows responsible corporate governance that we are not trying to ramp up the SP something I thing the FDA would not tolerate. Credibility and reputation is important during this critical stage of the development
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.